Lab World Plus Health Diagnostic Services Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.64 M
as on 10-12-2024
- Revenue -22.04%
(FY 2018)
- Profit -67.66%
(FY 2018)
- Ebitda -48.82%
(FY 2018)
- Net Worth 55.53%
(FY 2018)
- Total Assets 80.34%
(FY 2018)
About Lab World Plus Health Diagnostic Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.64 M.
Kishan Agarwal and Ashish Bhosle serve as directors at the Company.
- CIN/LLPIN
U74999MH2015PTC269114
- Company No.
269114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lab World Plus Health Diagnostic Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Bhosle  | Director | 20-Jan-2017 | Current |
| Kishan Agarwal | Additional Director | 01-Oct-2018 | Current |
Financial Performance of Lab World Plus Health Diagnostic Services.
Lab World Plus Health Diagnostic Services Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 22.04% decrease. The company also saw a substantial fall in profitability, with a 67.66% decrease in profit. The company's net worth Soared by an impressive increase of 55.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lab World Plus Health Diagnostic Services?
In 2018, Lab World Plus Health Diagnostic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Aug 2017 | ₹2.97 M | Open |
Others Creation Date: 05 Feb 2016 | ₹2.68 M | Open |
How Many Employees Work at Lab World Plus Health Diagnostic Services?
Lab World Plus Health Diagnostic Services has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lab World Plus Health Diagnostic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lab World Plus Health Diagnostic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
